Blog: Dangerous Drugs

May 17, 2023

Every year, defective products cause thousands of consumer injuries and deaths. While many defective products have the potential to inflict life-changing damage, certain items have historically resulted in a greater number of serious incidents and recalls than others. From exploding airbags to toxic drugs, learn from our Pittsburgh defective product attorneys about the most dangerous types of defective products that have entered the market in recent years. Auto Parts Our Pittsburgh car accident lawyers have...

Can I File a Medical Malpractice Lawsuit After a Drug Recall?

Jun 21, 2021

If you are prescribed a dangerous or defective drug, you may have grounds for one or two different types of civil lawsuits. You may be able to file a medical malpractice lawsuit if the physician who prescribed the drug knew or should have known that it had been recalled or was otherwise unsafe. If you cannot file a medical malpractice lawsuit, you may still have grounds for a product liability claim against the pharmaceutical company...

NuvaRing manufacturer fought for no risk warning on labels

Dec 18, 2013

In 2002, the Dutch drug manufacturer, Organon, released NuvaRing, one of the most popular contraceptive drugs in history. The multi-billion dollar product, NuvaRing, was marketed as the first hormonal contraceptive ring in the entire world. Banking on convenience, it was allowed women to refrain from taking the pill and was hailed as the greatest advancement in birth control technology since the sixties. However, before NuvaRing could be sold in the United States, it had to...

Amylin Pharmaceutical’s Byetta among worst of diabetes drugs to be called into court

Nov 25, 2013

It was announced only a few weeks ago that people who have filed claims against Bristol-Myers Squibb and its subsidiary, Amylin Pharmaceuticals, in regards to the drug Byetta, will be moving forward with their cases in due time. Recent developments over the course of the past few months have led to a judge overseeing dozens of lawsuits in a U.S. District Court for California's Southern District. All of the claims allege that the makers of...

Januvia lawsuits hit U.S. District Court, many more likely to follow

Nov 25, 2013

There are now more than 150 lawsuits involving Januvia and other kinds of Type 2 diabetes drugs, according to recent court filings. Federal proceedings have begun in a United States District Court in the Southern District of California. Every single claim filed alleges that physicians and their patients were not provided with enough knowledge about the product in regards to pancreas-related health problems, pancreatic cancer, and thyroid cancer. Januvia and similar incretin mimetic drugs like...

Use of drugs like Lipitor could reach 70 million with new guidelines

Nov 22, 2013

New U.S. guidelines for treating people with high cholesterol could literally double the number of people on drugs such as Lipitor. Many are surprised at this news because of the legal controversies surrounding Lipitor and its propensity to develop Type 2 diabetes in cholesterol patients. However, "Big Medical" and pharmaceutical conglomerates have begun marketing them as competent in the fight against heart disease. Since heart disease is the number one killer in the United States,...

Johnson & Johnson, Janssen Pharmaceuticals pay out $15 million over past two months in Topamax cases

Nov 22, 2013

On November 18, a Pennsylvania state jury awarded $11 million to the mother of a little boy who was born with a cleft palate as a result of her prescription to the dangerous drug, Topamax. Johnson & Johnson's subsidiary, Janssen Pharmaceuticals, argued that they supplied adequate warnings of the safety risks surrounding the anti-seizure drug, but the jury disagreed. This is actually the second case of Topamax litigation in the past two months. In October,...

Bone fractures and breaks added to the lengthening list of Actos side effects

Nov 21, 2013

Serious health issues regarding Actos and its relationship to bone fractures have been capturing the attention of health professionals and Type 2 diabetes patients across the country and around the globe. For more than fourteen years, millions upon millions of Type 2 diabetes patients have been prescribed Takeda Pharmaceutical's Actos in an effort to fight the disease and regiment their blood-sugar. Amid the many dangerous side effects that have been reported about Actos over the years, the...

Johnson & Johnson pays $2.2 billion in Risperdal settlements

Nov 15, 2013

Last week, the Department of Justice and the FDA announced that Janssen Pharmaceuticals has pled guilty to misleading buyers of the drug Risperdal and selling it under fabricated pretenses. Johnson & Johnson and its subsidiary, Janssen, will pay a total of $2.2 billion in settlement money. $1.72 billion of the $2.2 billion is attributed to a civil settlement with federal and state governments. $485 million will be paid out under criminal fines and forfeitures. The...